Transition to Oral Antibiotics in Improving Soft Tissue Infection

Rationale for Early Transition

The World Society of Emergency Surgery guidelines support transitioning to oral antibiotics as soon as possible for patients with severe infections who are able to tolerate oral therapy and have documented clinical improvement, which includes patients with normalized white blood cell count, no fever, and improving swelling 1
Clinical improvement is documented by the absence of fever, reduction of pain, and improvement in swelling, which are key criteria for transitioning to oral antibiotics 2

Switching from IV to oral antibiotics within 48 hours in skin and soft tissue infections was successful in 95% of cases, with a median duration of IV therapy before switching of approximately 2-3 days in successful cases, according to a prospective multicenter trial 1

The American College of Emergency Physicians recommends Augmentin (amoxicillin-clavulanate) as an appropriate oral antibiotic for soft tissue infections, which continues coverage for streptococci, anaerobes, and methicillin-sensitive staphylococci 1
The Infectious Diseases Society of America recommends Bactrim (trimethoprim-sulfamethoxazole) as an appropriate oral antibiotic for MRSA coverage, with a dosage of 160/800 mg q12h 4, 5, 6

The World Society of Emergency Surgery guidelines recommend completing a total antibiotic course of 7-14 days (IV plus oral combined), depending on initial severity and rate of improvement, with an additional 7-10 days of oral therapy after 3 days of IV therapy 1, 4, 5

Patients should be reassessed at 48-72 hours after transitioning to oral antibiotics for continued defervescence, progressive reduction in erythema and swelling, no systemic symptoms, and stable or improving white blood cell count 2, 7

The World Society of Emergency Surgery guidelines recommend not transitioning to oral antibiotics if FNA results reveal abscess requiring drainage, cultures grow organisms resistant to proposed oral regimen, or deep space infection or necrotizing component is identified on imaging 1, 7
The Infectious Diseases Society of America recommends longer IV therapy (minimum 2 weeks) for Staphylococcus aureus bacteremia, even with clinical improvement, due to endocarditis risk 2